Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 24.00
Ask: 32.00
Change: 0.00 (0.00%)
Spread: 8.00 (33.333%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
CBA Live PriceLast checked at -
Ceiba Investments is an Investment Trust

To provide a regular level of income and substantial capital growth through investment in, and management of, a portfolio of Cuban real estate assets, with a focus on the tourism-related and commercial property sectors.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

3 Jun 2019 12:59

RNS Number : 9633A
Ceiba Investments Limited
03 June 2019
 

 

3 June 2019

CEIBA INVESTMENTS LIMITED

(TICKER CBA, ISIN: GG00BFMDJH11)

TRADING UPDATE

 

CEIBA Investments Limited ("CEIBA" or the "Company"), the largest listed foreign investor solely dedicated to investing in Cuba, is pleased to provide the following update on trading.

Q1 2019 Results

As announced on 29 May 2019, the Company's unaudited IFRS net asset value per share ("NAV") as at 31 March 2019 was US$1.5073 (31 December 2018 audited NAV: US$1.4937). This increase reflects US$1.9 million of net comprehensive income recognised during the quarter. This was principally attributable to US$3.4 million of dividend income received by the Company, net of non-controlling interests, from its equity investments in Cuban joint venture companies.

However, as a result of the strengthening of the British Pound during this period (GBP:US$ FOREX as at 31 March 2019 of 1.3053 compared to 1.2691 as at 31 December 2018), the unaudited IFRS NAV expressed in Sterling at 31 March 2019 was lower, at £1.1547, than as at 31 December 2018, £1.1770.

The non-IFRS unaudited NAV as at 31 March 2019 was US$1.5406 (31 December 2018: US$1.5288) or £1.1802 (31 December 2018: £1.2046). These figures include an adjustment recognising the full amount of US$5.0 million (£3.9 million) received from Aberdeen Standard Fund Managers Limited in connection with the execution of the Management Agreement (rather than deferring this amount over the five-year term of the Management Agreement as required by IFRS).

Strengthening of the US Cuban Embargo

The recent steps taken by the Trump administration to further strengthen the US Cuban Embargo, which has included limiting remittances, further restricting travel by US persons to Cuba and allowing Title III of the extraterritorial Helms-Burton Act to come into force, have resulted in a decline in US travel to the island and are expected to have a negative impact on the Cuban economy. In light of these aggressive steps, the Company is highly encouraged that Cuba continues to allow the timely transfer of hard currency to the foreign shareholders of the Cuban joint ventures in which the Company participates. The Company is also grateful for the immediate support provided by the European Union and various other countries in publicly repeating their long-standing determination that the application of Title III of the Helms-Burton Act is contrary to international law and confirming support for the companies under their jurisdiction having legitimate investments in Cuba.

The Spanish Cuban Debt Conversion Programme ("the Programme")

In April 2019, the Company announced that two Cuban joint venture companies in which CEIBA participates were awarded an aggregate amount of US$18.25 million under the Spanish Cuban Debt Conversion Programme. TosCuba S.A. (in which CEIBA has an economic interest of 40%) was awarded US$10 million in connection with the construction of the Meliã Trinidad Playa Hotel near Trinidad, Cuba, and Miramar S.A. (in which CEIBA has a 32.5% economic interest) was awarded US$8.25 million in connection with the Meliã Habana expansion project.

Under these awards, local currency invoices relating to services and materials received in Cuba in the course of the construction of the projects will be paid on behalf of the Cuban joint venture companies from Programme funds, thereby reducing the financing that CEIBA may have otherwise needed to provide. There is no obligation to reimburse funds awarded under the Programme.

In May 2019, TosCuba S.A. received the first US$2.5 million tranche of its award from the Programme.

Amended FINTUR Facility

On 31 May 2019, the Company amended its existing syndicated €24 million secured loan facility in favour of the Cuban finance company Casa Financiera FINTUR S.A. ("FINTUR") in order to extend to FINTUR a second tranche in the principal amount of €12 million, which will be repaid in instalments over 2 years. The Company's participation in this new tranche is €2 million. 

The Company has provided loan facilities to FINTUR since 2001 for a total aggregate amount of €140 million, which have been repaid in full without default. 

 

John Herring, Chairman of CEIBA Investments Limited, said:

 

"We are pleased by the Q1 results of the Company and the continuing progress being made with respect to our investment programmes. We are confident, notwithstanding the adverse recent steps taken by the US administration towards Cuba, that CEIBA's growing investment programmes will prove to be mutually beneficial to the Company and to the Cuban economy, Cuba and its people."

 

 

For further information, please contact:

 

Aberdeen Standard Fund Managers Limited

Sebastiaan Berger / Gary Jones / Christian Pittard

 

Tel: +44 (0)20 7463 6000

N+1 Singer

James Maxwell / James Moat (Corporate Finance)

James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

 

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKMGGVMFKGLZM
12
Date   Source Headline
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
3rd Jul 20234:41 pmRNSUpdate re Internalisation of Management
28th Jun 20236:16 pmRNSResult of AGM
28th Jun 20236:05 pmRNSNet Asset Value(s)
27th Apr 20234:03 pmRNSAnnual Financial Report - Replacement
27th Apr 20237:00 amRNSInternalisation of Management
27th Apr 20237:00 amRNSAnnual Financial Report
7th Feb 20231:07 pmRNSHolding(s) in Company
14th Dec 20221:14 pmRNSCorrection: Half-year Report
1st Dec 20227:00 amRNSService Providers and Registered Office
30th Nov 202212:22 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
1st Aug 20224:53 pmRNSAlternative Investment Fund Manager–Change of Name
4th Jul 202210:02 amRNSNet Asset Value(s)
16th Jun 20225:34 pmRNSResult of AGM
25th May 20223:38 pmRNSCorrection: Annual Financial Report
29th Apr 20229:45 amRNSAnnual Financial Report
23rd Feb 20227:00 amRNSNet Asset Value(s)
22nd Feb 20227:00 amRNSTrading Update
19th Jan 20224:48 pmRNSHolding(s) in Company
31st Dec 20211:27 pmRNSHolding(s) in Company
31st Dec 20211:26 pmRNSHolding(s) in Company
26th Nov 20214:34 pmRNSHolding(s) in Company
26th Nov 20213:24 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
28th Sep 20217:00 amRNSHalf-year Report
17th Jun 20212:47 pmRNSResult of AGM
28th Apr 20217:00 amRNSAnnual Financial Report
14th Apr 20217:00 amRNSListing of Convertible Bonds
31st Mar 202112:16 pmRNSTrading Statement
15th Jan 20217:00 amRNSNet Asset Value(s)
16th Dec 20207:00 amRNSTrading Statement
3rd Dec 20204:30 pmRNSResult of Extraordinary Meeting
13th Nov 20207:00 amRNSNotice of EGM
23rd Oct 20207:00 amRNSTrading Statement
9th Oct 20204:59 pmRNSHalf-year Report
29th Sep 20207:00 amRNSHalf-year Report
19th Jun 20204:00 pmRNSResult of AGM
8th Jun 20207:00 amRNSTrading Statement
20th May 20205:40 pmRNSNet Asset Value(s)
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.